Lamotrigine Neuraxpharm

Lamotrigine, the active ingredient in Lamotrigine Neuraxpharm, is an anticonvulsant presented as an oral tablet for oral use. It is prescribed for the treatment of epilepsy, including partial and generalized tonic‑clonic seizures, and for maintenance therapy in bipolar disorder to help stabilize mood.

GNH USA supplies Lamotrigine Neuraxpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Lamotrigine is used in the management of seizure disorders and mood stabilization in bipolar disorder.

Partial seizures (focal onset): reduces seizure frequency and severity. Generalized tonic‑clonic seizures: decreases occurrence of convulsive episodes. Bipolar disorder (maintenance therapy): helps prevent mood episode recurrence and stabilizes mood.

Lamotrigine may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea - Rash

Serious or Rare Side Effects: - Stevens‑Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) - Severe hypersensitivity reactions - Aseptic meningitis - Blood dyscrasias (e.g., agranulocytosis)

Before prescribing Lamotrigine, several safety considerations should be evaluated.

Assess renal and hepatic function: adjust therapy if impairment is present. Review concomitant medications: avoid drugs that significantly alter lamotrigine levels. Monitor for skin reactions: discontinue at first sign of rash. Counsel women of childbearing potential: discuss unknown pregnancy risks. Educate on adherence: abrupt discontinuation may increase seizure frequency. Store at ambient temperature: keep in original container, protect from moisture and light.

Lamotrigine can interact with other medicines, affecting its plasma concentration or increasing toxicity.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, risk of toxicity. - Carbamazepine, phenytoin, phenobarbital: reduce lamotrigine levels, may diminish efficacy. - Combined oral contraceptives: may lower lamotrigine levels, risk of breakthrough seizures.

Moderate Interactions (Monitor Closely): - Serotonergic agents (e.g., SSRIs): rare risk of serotonin syndrome. - Other antiepileptics (e.g., levetiracetam): monitor seizure control. - Warfarin: occasional effect on INR, monitor coagulation.